{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T19:02:29Z","timestamp":1648839749971},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T00:00:00Z","timestamp":1438646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s11606-015-3458-4","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T11:58:56Z","timestamp":1438603136000},"page":"1581-1583","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Good Intentions, Unintended Consequences, and Unrealized Benefits"],"prefix":"10.1007","volume":"30","author":[{"given":"John D.","family":"FitzGerald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,4]]},"reference":[{"issue":"Suppl 1","key":"3458_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar1906","volume":"8","author":"G Nuki","year":"2006","unstructured":"Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther. 2006;8(Suppl 1):S1.","journal-title":"Arthritis Res Ther"},{"key":"3458_CR2","unstructured":"U.S. Food and Drug Administration. FDA Takes Action to Stop the Marketing of Unapproved Injectable Drugs Containing Colchicine. Online. 2-6-2008."},{"issue":"4","key":"3458_CR3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"RA Terkeltaub","year":"2010","unstructured":"Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum. 2010;62(4):1060\u20131068.","journal-title":"Arthritis Rheum"},{"issue":"15","key":"3458_CR4","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJMc1007963","volume":"363","author":"J Woodcock","year":"2010","unstructured":"Woodcock J, Okada S. Incentives for drug development-the curious case of colchicine. N Engl J Med. 2010;363(15):1484\u20131485.","journal-title":"N Engl J Med"},{"key":"3458_CR5","author":"AS Kesselheim","year":"2015","unstructured":"Kesselheim AS, Franklin JM, Kim SC, Seeger JD, Solomon DH. Reductions in use of colchicine after FDA enforcement of market exclusivity in a commercially insured population. J Gen Intern Med. 2015. doi: 10.1007\/s11606-015-3285-7 .","journal-title":"J Gen Intern Med"},{"key":"3458_CR6","unstructured":"Sell D. URL Pharma may no longer be cash cow in Philadelphia. Online. 3-3-2013. Pittsburgh Post-Gazette."},{"key":"3458_CR7","unstructured":"Cohen S. The Law of Unitended Consequences Rears Its Head. The Rheumatologist 2010."},{"key":"3458_CR8","unstructured":"DiMasi JA. Tufts Center for the Study of Drug Development Briefing Cost of Developing a New Drug. http:\/\/csdd.tufts.edu\/news\/complete_story\/cost_study_press_event_webcast . 3-2-2014."},{"issue":"22","key":"3458_CR9","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1182\/blood-2013-03-490003","volume":"121","author":"C Abboud","year":"2013","unstructured":"Abboud C, Berman E, Cohen A, Cortes J, DeAngelo D, Deininger M, et al. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood. 2013;121(22):4439\u20134442.","journal-title":"Blood"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-015-3458-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-015-3458-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-015-3458-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:48:43Z","timestamp":1559396923000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-015-3458-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,4]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3458"],"URL":"https:\/\/doi.org\/10.1007\/s11606-015-3458-4","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,4]]}}}